Abiopharma

🔍 Mackay Leo S. Jr. (Director)

Company: COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 25 shares of Deferred Restricted Stock Units (Derivative)
  Date: 2026-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,748.34 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2
• Acquired 34 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,438.03 | transaction_form_type: 4 | Footnotes: F3, F3, F4, F4
• Acquired 22 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 4,192.83 | transaction_form_type: 4 | Footnotes: F5, F5, F6, F6

Footnotes:

• F1: Reflects deferred restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding deferred restricted stock units. Each deferred restricted stock unit represents a right to receive one share of Class A Common Stock of the Company.
• F2: The deferred restricted stock units are fully vested and will be settled upon the Reporting Person's termination of service from the Board.
• F3: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a right to receive one share of Class A Common Stock of the Company.
• F4: The restricted stock units are fully vested. The Reporting Person has elected, pursuant to the Company's Non-Employee Director Compensation Guidelines (the "Guidelines"), to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability).
• F5: Reflects restricted stock units received pursuant to dividend equivalent rights accrued on previously outstanding restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Company's Class A Common Stock.
• F6: The restricted stock units will vest fully on June 2, 2027. The Reporting Person has elected, pursuant to the Company's Guidelines, to defer settlement of such restricted stock units until the first to occur of (1) a change in control, (2) the death or permanent disability of the Reporting Person, or (3) the first July 1 following the date of the Reporting Person's termination of service (other than due to death or permanent disability).